There are currently 26 million people with heart failure worldwide.
As the disease progresses, patients suffer from worsening symptoms and frequent decompensation leading to costly hospital readmissions. Heart failure is the number one cause of death and cost driver in modern healthcare systems.
Patients with end-stage heart failure are refractory to medical therapy and need mechanical hemodynamic support. However, current hemodynamic support options are extremely costly and require open heart surgery, making them a seldom offered solution.